Literature DB >> 9275041

Stimulation of cell proliferation by calcium and a calcimimetic compound.

M Mailland1, R Waelchli, M Ruat, H G Boddeke, K Seuwen.   

Abstract

Some mesenchymal cells respond to stimulation by specific cations with increased cell proliferation. In the present study we have investigated whether the parathyroid/kidney/brain calcium-sensing receptor (PCaR) can mediate such mitogenic responses. We have expressed the recombinant rat PCaR in CCL39 hamster fibroblasts, which do not express a detectable endogenous cation sensor. The transfected cells responded to increased extracellular calcium concentrations ([Ca2+]e) with strong inositol phosphate (IP) formation, which was insensitive to pertussis toxin treatment of cells. We could not detect negative coupling of the receptor to adenylyl cyclase. The calcimimetic NPS R-568 left-shifted the concentration-response curve for [Ca2+]e-induced IP formation and increased the maximal response. In [3H]thymidine incorporation experiments, increasing [Ca2+]e from 1 to 4 mM was found to stimulate DNA synthesis weakly, but significantly. A strong potentiation of this response was observed in the presence of NPS R-568. [Ca2+]e and NPS R-568 also synergized to increase cell numbers in cultures maintained in defined medium. In contrast to our expectations, no significant stimulation of IP formation or cell proliferation could be observed after stimulation of cells with the reported PCaR agonist gadolinium (Gd3+) or with aluminum (Al3+), which stimulates osteoblast proliferation. Gd3+ actually inhibited IP formation stimulated by increased [Ca2+]e as well as by thrombin and AlF4-, indicating toxicity. However, submaximal receptor stimulation by Gd3+ was evident when intracellular calcium transients were measured in fluo-3-loaded cells. Our data show that PCaR can stimulate cell proliferation when expressed in an appropriate cellular context. However, it is unlikely that PCaR mediates the strong mitogenic effects elicited by the cations Gd3+ and Al3+ observed in osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275041     DOI: 10.1210/endo.138.9.5417

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors.

Authors:  Min Pi; L Darryl Quarles
Journal:  J Cell Biochem       Date:  2005-08-15       Impact factor: 4.429

Review 2.  The calcium-sensing receptor in bone.

Authors:  Toru Yamaguchi
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

3.  Osteoblasts play key roles in the mechanisms of action of strontium ranelate.

Authors:  T C Brennan; M S Rybchyn; W Green; S Atwa; A D Conigrave; R S Mason
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 4.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

5.  Effects of extracellular iron concentration on calcium absorption and relationship between Ca2+ and cell apoptosis in Caco-2 cells.

Authors:  Li Wang; Qing Li; Xiang-Lin Duan; Yan-Zhong Chang
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 6.  Role of calcium and other trace elements in the gastrointestinal physiology.

Authors:  P Kirchhoff; J-P Geibel
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

7.  Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.

Authors:  Jason Gilster; Kathy Bacon; Katie Marlink; Brett Sheppard; Clifford Deveney; Michael Rutten
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 8.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

9.  Calcium phosphate nanoparticles: a future therapeutic platform for the treatment of osteomyelitis?

Authors:  Tejal A Desai; Vuk Uskoković
Journal:  Ther Deliv       Date:  2013-06

10.  A novel 3-D mineralized tumor model to study breast cancer bone metastasis.

Authors:  Siddharth P Pathi; Christine Kowalczewski; Ramya Tadipatri; Claudia Fischbach
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.